1. Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid-resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya.
- Author
-
Mwangi ZM, Ireri S, Opwaka H, Otieno L, Simam J, Onyambu FG, and Mukiri N
- Subjects
- Humans, Kenya, Bacterial Proteins genetics, Mutation, Sensitivity and Specificity, DNA-Directed RNA Polymerases genetics, Drug Resistance, Multiple, Bacterial genetics, Catalase genetics, Genotype, Real-Time Polymerase Chain Reaction methods, Oxidoreductases genetics, Mycobacterium tuberculosis genetics, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis isolation & purification, Isoniazid pharmacology, Rifampin pharmacology, Tuberculosis, Multidrug-Resistant microbiology, Antitubercular Agents pharmacology, Microbial Sensitivity Tests
- Abstract
Background: Drug-resistant tuberculosis (DR-TB) poses a major global challenge to public health and therapeutics. It is an emerging global concern associated with increased morbidity and mortality mostly seen in the low- and middle-income countries. Molecular techniques are highly sensitive and offer timely and accurate results for TB drug resistance testing, thereby positively influencing patient management plan., Methods: The study was carried out at the National Tuberculosis Reference Laboratory (NTRL) in Kenya in the period between January and October 2022. A total of 243 Mycobacterium tuberculosis (M.tb) clinical isolates were included in the study. These isolates comprised of 50 isolates with mutations in rpoB, 51 isolates with katG mutations, 51 isolates with mutations in inhA, and 91 M.tb isolates lacking mutations in these genes based on Genotype MTBDRplus results. DNA from the isolates was extracted using the FluoroLyse extraction kit. Real-time polymerase chain reaction targeting the rpoB, InhA, and katG genes was performed using the FluoroType MTBDR amplification mix. Isolates with discordant results between Genotype MTBDRplus and FluoroCycler® MTBDR assays underwent targeted sequencing for the respective genes, then, sequences were analyzed for mutations using Geneious version 11.0 software., Results: The sensitivity of the Fluorocycler XT MTBDR assay for the detection of mutations that confer drug resistance was 86% (95% confidence interval [CI] 73.0-94.0) for rpoB, 96% (95% CI 87-100) for katG and 92% (95% CI 81-98) for inhA. The assay's specificity was 97% (95% CI 93-99) for rpoB, 98% (95% CI 96-100) for katG, and 97% (95% CI 93-99) for inhA., Conclusion: The diagnostic accuracy of FluoroType MTBDR for the detection of mutations conferring resistance to rifampicin and isoniazid was high compared with that of Genotype MTBDRplus and demonstrates its suitability as a replacement assay for Genotype MTBDRplus., (Copyright © 2024 Copyright: © 2024 International Journal of Mycobacteriology.)
- Published
- 2024
- Full Text
- View/download PDF